HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilms' tumor and preferentially expressed antigen of melanoma in patients with myeloid neoplasms treated with azacytidine.

AuthorsPhilip T Murphy, Sinead Moran, John Quinn, Siobhan Glavey, Paul Kennedy
JournalEuropean journal of haematology (Eur J Haematol) Vol. 103 Issue 5 Pg. 527 (Nov 2019) ISSN: 1600-0609 [Electronic] England
PMID31407407 (Publication Type: Letter)
Chemical References
  • Antigens, Neoplasm
  • Antimetabolites, Antineoplastic
  • PRAME protein, human
  • WT1 Proteins
  • WT1 protein, human
  • Azacitidine
Topics
  • Antigens, Neoplasm (genetics)
  • Antimetabolites, Antineoplastic (pharmacology, therapeutic use)
  • Azacitidine (pharmacology, therapeutic use)
  • Humans
  • Myeloproliferative Disorders (diagnosis, drug therapy, genetics, mortality)
  • Prognosis
  • Treatment Outcome
  • WT1 Proteins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: